Anna J. Podolanczuk, MD, MS

Assistant Professor of Medicine at Columbia University Medical Center

 

Bio

Dr. Podolanczuk is an attending physician at New York Presbyterian/Columbia University specializing in advancing the care of patients with interstitial lung disease and pulmonary fibrosis. She is also board-certified in critical care medicine and attends in the medical intensive care unit and other critical care services at New York Presbyterian. Dr. Podolanczuk completed her training in internal medicine and pulmonary/critical care medicine at Columbia University and pursued additional training in advanced pulmonary diseases, as well as translational and epidemiological research methods through Columbia’s T32 training program in lung science and Mailman School of Public Health Masters of Science in patient oriented research. Her research focuses on identifying and characterizing novel risk factors for interstitial lung disease in humans, with a focus on CT and blood biomarkers of subclinical interstitial lung disease, environmental factors that contribute to pulmonary fibrosis, and the connection between cardiovascular disease risk factors and pulmonary fibrosis. She is NIH funded to study the role of high density lipoproteins in clinical and subclinical interstitial lung disease. She is also a site investigator for several multi-center clinical trials of novel therapies for pulmonary fibrosis.

Education and Training

Undergraduate:
B.S. in Neuroscience, Brown University, Providence, RI, 1998-2002
Medical School:
New York University School of Medicine, New York, NY  2003-2008
Residency:
Internal Medicine, Columbia University Medical Center, New York, NY, 2008-2011
Fellowship(s):
Pulmonary and Critical Care Medicine, Columbia University Medical Center, New York, NY, 2012-2015
Advanced Pulmonary Disease Academic Research, Columbia University Medical Center, New York, NY, 2015-2016



Selected Honors and Awards

  • 2016 Department of Medicine Fellows’ Research Award, Columbia University
  • 2014-2016 American Thoracic Society Travel Award
  • 2014-2015 Chief Fellow, Pulmonary & Critical Care, Columbia University
  • 2011 Meltzer Ethics Fellowship, Columbia University
  • 2008 Alpha Omega Alpha
  • 2008 AMWA Achievement Citation, NYU School of Medicine
  • 2002 Academic Honors, Brown University

Clinical

For appointments: 

Columbia ILD and PFF Care Center
Columbia University Medical Center
161 Fort Washington Ave, Room 3-321A
New York, NY 10032
Phone: 212 - 305 - 8203
Fax: 212 - 305 - 8426

Specialties

  • Pulmonary Disease Medicine
  • Critical Care Medicine

Clinical Expertise

  • Interstitial Lung Disease
  • Idiopathic Pulmonary Fibrosis

Clinical Centers

Board Certifications

  • Internal Medicine, 2011
  • Pulmonary Medicine, 2014
  • Critical Care Medicine, 2016

Research

Contact Information: 

Pulmonary & Intensive Care Translational Outcomes Research (PICTOR) Group
622 West 168th Street, PH-9, room 214
New York, NY 10032
Phone: 212 - 342 - 4675
Email: ajp2158@cumc.columbia.edu
Website: www.PictorGroup.org

Research Interests

  • Subclinical interstitial lung disease
  • Cardiovascular disease and risk factors in pulmonary fibrosis
  • Novel therapies for idiopathic pulmonary fibrosis

Selected Funding

  • T32 HL105323 Columbia Training Program in Lung Science (PI: Bhattacharya; Fellow: Podolanczuk; completed)
  • K23 HL140199 Role of High Density Lipoproteins in Interstitial Lung Disease (PI: Podolanczuk)
  • American Lung Association Dalsemer Grant Household Dust Microbiome and Idiopathic Pulmonary Fibrosis (PI: Podolanczuk)

Selected Publications

  1. Podolanczuk AJ, Oelsner EC, Barr RG, Bernstein EJ, Hoffman EA, Easthausen IJ, Hinckley Stukovsky K, RoyChoudhury A, Michos ED, Raghu G, Kawut SM, Lederer DJ. High Attenuation Areas on Chest CT and Clinical Respiratory Outcomes in Community-Dwelling Adults. Am J Respir Crit Care Med. 2017 Dec 1;196(11):1434-1442. PMID: 28613921
  2. Sack CS, Doney SC, Podolanczuk AJ, Hooper LG, Seixas NS, et al. Occupational Exposures and Subclinical Interstitial Lung Disease: The Multi-Ethnic Study of Atherosclerosis (MESA) Air- Lung Study. Am J Respir Crit Care Med. 2017 Oct 15;196(8):1031-1039. PMID: 28753039.
  3. Kim JS, Podolanczuk AJ, Borker P, Kawut SM, Raghu G, Kaufman JD, Hinckley Stukovsky KD, Hoffman EA, Barr RG, Gottlieb DJ, Redline SS, Lederer DJ. Obstructive sleep apnea and subclinical interstitial lung disease in MESA. Ann Am Thorac Soc. 2017 Dec;14(12):1786-1795. PMID: 28613935.
  4. Armstrong HF, Podolanczuk AJ, Barr RG, Oelsner EC, Kawut SM, Hoffman EA, Tracy R, Kaminski N, McClelland RL, Lederer DJ. Serum Matrix Metalloproteinase-7, Respiratory Symptoms, and Mortality in Community-dwelling Adults: The Multi-Ethnic Study of Atherosclerosis. Am J Respir Crit Care Med. 2017 Nov 15;196(10):1311-1317. PMID: 28570100.
  5. Podolanczuk AJ, Lederer DJ. Patient-Centered Outcomes in Idiopathic Pulmonary Fibrosis: Full Steam Ahead. Am J Resp Crit Care Med. 2017 Sep 15;196(6):674-675. PMID: 28609111.
  6. Restivo M, Podolanczuk A, Kawut S, Raghu G, Leary P, Barr RG, Lederer DL. Antacid use and subclinical interstitial lung disease: the MESA Study. Eur Respir J. 2017 May 19;49(5). PMID: 28526800.
  7. Podolanczuk AJ, Raghu G, Tsai M, Kawut SM, Peterson E, Sonti R, Rabinowitz D, Johnson C, Barr RG, Hinckley Stukovsky K, Hoffman EA, Carr JJ, Ahmed FS, Jacobs D, Watson K, Shea SJ, Lederer DJ. Cholesterol, Lipoproteins and Subclinical Interstitial Lung Disease: The MESA Study. Thorax. 2017 May;72(5):472-474. PMID: 28130491; PMCID: PMC5388565.
  8. Podolanczuk AJ, Oelsner EC, Barr RG, Hoffman EA, Armstrong HF, Austin JHM, Basner RC, Bartels MN, Christie JD, Enright PL, Gochuico BR, Stukovsky KH, Kaufman JD, Nath PH, Newell JD, Palmer SM, Rabinowitz D, Raghu G, Sell JL, Sieren J, Sonavane SK, Tracy RP, Watts JR, Williams K, Kawut SM, Lederer DJ. High attenuation areas on chest CT in community-dwelling adults: The MESA Study. Eur Resp J. 2016 Nov; 48(5): 1442-1452. PMID: 27471206. PMCID: PMC5089905.

View Dr. Podolanczuk's list of publications